23 Questions with Andrew Wilson on Plasmid Manufacturing
Endpoints Webinar: 7 questions gene therapy developers should ask their CDMO (and what...
Comprehensive characterization of plasmid and AAV gene therapy products with Forge...
A Novel Role for the Adenovirus L4 Region 22K and 33K Proteins in Adeno-Associated Virus...
Scaling to New Heights: Robust Scale Up from Shake Flask to Commercial AAV Manufacturing...
23 Questions with Keerthana Subramanian on Downstream Process Development
23 Questions with Claire Marasco on Global Regulatory Strategies
Forge Biologics’ cGMP Compliant and Commercially Viable Bespoke Affinity Chromatography...
.png)
.png)
